AIM: This study aimed to determine the effect of the CYP2D6 genotype on the length of hospitalization stay for patients treated for major depressive disorder. METHODS: A total of 149 inpatients with a diagnosis of major depressive disorder at the Institute of Living, Hartford Hospital (CT, USA), were genotyped to detect altered alleles in the CYP2D6 gene. Prospectively defined drug metabolism indices (metabolic reserve, metabolic alteration and allele alteration) were determined quantitatively and assessed for their relationship to length of hospitalization stay. RESULTS: Hospital stay was significantly longer in deficient CYP2D6 metabolizers (metabolic reserve <2) compared with functional or suprafunctional metabolizers (metabolic reserve ≥2; 7.8 vs 5.7 days, respectively; p = 0.002). CONCLUSION: CYP2D6 enzymatic functional status significantly affected length of hospital stay, perhaps due to reduced efficacy or increased side effects of the medications metabolized by the CYP2D6 isoenzyme. Functional scoring of CYP2D6 alleles may have a substantial impact on the quality of care, patient satisfaction and the economics of psychiatric treatment.
AIM: This study aimed to determine the effect of the CYP2D6 genotype on the length of hospitalization stay for patients treated for major depressive disorder. METHODS: A total of 149 inpatients with a diagnosis of major depressive disorder at the Institute of Living, Hartford Hospital (CT, USA), were genotyped to detect altered alleles in the CYP2D6 gene. Prospectively defined drug metabolism indices (metabolic reserve, metabolic alteration and allele alteration) were determined quantitatively and assessed for their relationship to length of hospitalization stay. RESULTS: Hospital stay was significantly longer in deficient CYP2D6 metabolizers (metabolic reserve <2) compared with functional or suprafunctional metabolizers (metabolic reserve ≥2; 7.8 vs 5.7 days, respectively; p = 0.002). CONCLUSION:CYP2D6 enzymatic functional status significantly affected length of hospital stay, perhaps due to reduced efficacy or increased side effects of the medications metabolized by the CYP2D6 isoenzyme. Functional scoring of CYP2D6 alleles may have a substantial impact on the quality of care, patient satisfaction and the economics of psychiatric treatment.
Authors: Werner Steimer; Konstanze Zöpf; Silvia von Amelunxen; Herbert Pfeiffer; Julia Bachofer; Johannes Popp; Barbara Messner; Werner Kissling; Stefan Leucht Journal: Clin Chem Date: 2004-06-17 Impact factor: 8.327
Authors: Francis X Brennan; Kathryn R Gardner; Jay Lombard; Roy H Perlis; Maurizio Fava; Herbert W Harris; Rachel Scott Journal: Prim Care Companion CNS Disord Date: 2015-04-16
Authors: Paul Y Takahashi; Euijung Ryu; Jyotishman Pathak; Gregory D Jenkins; Anthony Batzler; Matthew A Hathcock; John Logan Black; Janet E Olson; James R Cerhan; Suzette J Bielinski Journal: Pharmgenomics Pers Med Date: 2017-02-14
Authors: Anne B Koopmans; David J Vinkers; Igmar T Poulina; Petra J A Gelan; Ron H N van Schaik; Hans W Hoek; Peter N van Harten Journal: Front Psychiatry Date: 2018-08-07 Impact factor: 4.157